Feb. 12, 2020 11:00 UTC
LONDON–(BUSINESS WIRE)– Technavio has been monitoring the veterinary pain management market and it is poised to grow by USD 615.4 million during 2020-2024, progressing at a CAGR of 9% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200212005312/en/
Technavio has published a new market research report on the veterinary pain management market from 2020-2024. (Graphic: Business Wire)
High prevalence of painful and inflammatory diseases in animals has been instrumental in driving the growth of the market. However, high cost associated with pet care might hamper market growth. Request a free sample report
Veterinary Pain Management Market 2020-2024: Segmentation
Veterinary Pain Management Market is segmented as below:
Product
Geographic segmentation
- North America
- Europe
- Asia
- ROW
To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR40044
Veterinary Pain Management Market 2020-2024: Scope
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. Our veterinary pain management market report covers the following areas:
- Veterinary Pain Management Market Size
- Veterinary Pain Management Market Trends
- Veterinary Pain Management Market Industry Analysis
This study identifies rising demand for pet insurance with growing animal health expenditure as one of the prime reasons driving the veterinary pain management market growth during the next few years.
Veterinary Pain Management Market 2020-2024: Vendor Analysis
We provide a detailed analysis of around 25 vendors operating in the veterinary pain management market, including some of the vendors such as Bayer AG, Boehringer Ingelheim International GmbH, Cadila Healthcare Ltd., Chanelle Pharma Group, Daiichi Sankyo Co. Ltd., Dechra Pharmaceuticals Plc, Elanco Animal Health Inc., Merck & Co. Inc., Norbrook Holdings Ltd. and Zoetis Inc. Backed with competitive intelligence and benchmarking, our research reports on the veterinary pain management market are designed to provide entry support, customer profile and M&As as well as go-to-market strategy support.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Technavio’s SUBSCRIPTION platform
Veterinary Pain Management Market 2020-2024: Key Highlights
- CAGR of the market during the forecast period 2020-2024
- Detailed information on factors that will assist veterinary pain management market growth during the next five years
- Estimation of the veterinary pain management market size and its contribution to the parent market
- Predictions on upcoming trends and changes in consumer behavior
- The growth of the veterinary pain management market
- Analysis of the market’s competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of veterinary pain management market vendors
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200212005312/en/